Pregled bibliografske jedinice broj: 857425
Diagnostic performance of a point-of-care glucose analyzer in gestational diabetes
Diagnostic performance of a point-of-care glucose analyzer in gestational diabetes // Point of Care: The Journal of Near-Patient Testing & Technology
Kopenhagen, Danska, 2016. str. 114-114 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 857425 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Diagnostic performance of a point-of-care glucose analyzer in gestational diabetes
Autori
Vučić Lovrenčić, Marijana ; Božičević, Sandra ; Radišić Biljak, Vanja ; Prašek, Manja
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Point of Care: The Journal of Near-Patient Testing & Technology
/ - , 2016, 114-114
Skup
AACC CPOCT 26th International Symposium:The Benefits and Challenges of Point-of-Care Testing Across the Clinical Spectrum
Mjesto i datum
Kopenhagen, Danska, 21.09.2016. - 24.09.2016
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
gestational diabetes, diagnosis, point-of-care glucose
Sažetak
Background: Oral glucose tolerance test (oGTT) with laboratory mesurement of venous plasma glucose (VPG) at fasting, 1 and 2 hours after a 75g glucose load is the recommended diagnostic procedure for gestational diabetes mellitus (GDM). The inconvenience of multiple venipunctures and notorious instability of glucose in venous blood samples, together with the complexity of the oGTT procedure seriously compromise the choice of the GDM diagnostic test procedure, particularly in remote and under-resourced areas. Considering the dramatically rising prevalence and recently introduced recommendations for universal screening ofGDM, suitable alternatives for simplifying GDMdiagnostic procedure are urgently needed in order to provide appropriate level of pregnancy health-care and improve patient outcomes. Aim: The aim of this study was to validate the diagnostic performance of the Nova StatStrip Glucose point-of-care (StatStrip) analyzer (Nova Biomedical, USA), designed and aproved for hospital use, in the GDM diagnosis. Considering a lack of defined cut-points for capillary plasma glucose (CPG) in GDM diagnosis, we also aimed to determine a set of StatStrip- specific CPG diagnostic criteria. Methods: After providing informed consent, CPG was sampled and StatStrip glucose measured at fasting (F-CPG), 1- and 2- hour after a 75g oral glucose load. Blood samples for VPG were collected within 5 minutes of respective CPG sampling in heparin tubes, immediately refrigerated, processed and analysed within 30 minutes with the reference laboratory procedure (hexokinase, Olympus AU400, Beckman Coulter, USA). Glycaemic status was classified as either normoglycaemic (NG) or GDM, according toWHO-2013 venous plasma-based criteria.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Klinička bolnica "Merkur",
Klinika za dijabetes, endokrinologiju i bolesti metabolizma Vuk Vrhovac
Citiraj ovu publikaciju:
Časopis indeksira:
- Scopus